News | February 02, 2012

Aria Health First on East Coast to Use Epoch System to Treat Arrhythmias

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D.,

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D., FACC Scott Spielman, M.D., FACC and Bradley Bacik, DO, FACC, are the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System, to perform robotic ablation of heart arrhythmias.


February 2, 2012 — Aria Health, the largest healthcare provider in Northeast Philadelphia and Bucks County, is the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System. This innovative technology allows electrophysiologists to treat many types of cardiac arrhythmias, or heart rhythm disorders, with robotic-driven catheter ablation procedures.

Housed in the heart center at Aria Health’s Torresdale Campus, Epoch offers many advantages over conventional treatment methods, according to Scott Spielman, M.D., FACC, director of Aria’s electrophysiology laboratory.

"Standard catheters used for ablation are fairly stiff, making them difficult to guide and raising the risk of perforating heart tissue,” said Spielman.  “The Epoch system employs a soft, floppy catheter which enables us to complete procedures in a shorter time period with greater safety.”

The new system reduces patient radiation exposure by two-thirds, and is effective for treating ventricular arrhythmias as well as other types of abnormal heart rhythms.

“This allows us to get a catheter tip to sites inside the complex internal anatomy with less force and more precision,” said Roger Marinchak, M.D., FACC, an electrophysiologist at Aria Health.  “This causes less risk of causing perforation injury to structures that one doesn’t want to ablate or hurt."

As the United States population ages, the number of people with atrial fibrillation (AF) - the most common type of serious arrhythmia - will grow, says Aria electrophysiologist Bradley Bacik, DO, FACC. While AF is a chronic condition that cannot be cured, he adds, ablation treatments available at Aria Health can substantially reduce symptoms.

For more information: www.ariahealth.org


Related Content

News

April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...

Home April 29, 2026
Home
News

April 24, 2026 — Johnson & Johnson recently announced the initiation of the PERSIGMA randomized controlled trial (RCT) ...

Home April 27, 2026
Home
News

April 26, 2026 – New results from the pivotal multicenter trial FULCRUM-VT show that ultra-low temperature ablation ...

Home April 27, 2026
Home
News

April 13, 2026 — Johnson & Johnson has announced favorable 12-month interim effectiveness and safety results from ...

Home April 13, 2026
Home
News

In a milestone for Broward Health in Ft. Lauderdale, Fla., Jose L. Baez-Escudero, M.D., chief of cardiology and ...

Home March 24, 2026
Home
News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
News

Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...

Home January 22, 2026
Home
News

Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...

Home January 21, 2026
Home
Feature | Kyle Hardner

Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...

Home January 09, 2026
Home
News

Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...

Home January 06, 2026
Home
Subscribe Now